Nu Skin Enterprises, Inc. (NUS)

Market Cap	677.46M
Revenue (ttm)	1.90B
Net Income (ttm)	-3.31M
Shares Out	49.67M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	11.32
Dividend	$0.24 (1.76%)
Ex-Dividend Date	May 31, 2024

Volume	363,151
Open	13.82
Previous Close	13.86
Day's Range	13.38 - 13.85
52-Week Range	11.73 - 37.15
Beta	1.13
Analysts	Hold
Price Target	20.83 (+52.6%)
Earnings Date	May 8, 2024

About NUS

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care pro...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• IPO Date: Nov 21, 1996
• Employees: 3,700
• Stock Exchange: NYSE
• Ticker Symbol: NUS

Financial Performance

In 2023, NUS's revenue was $1.97 billion, a decrease of -11.53% compared to the previous year's $2.23 billion. Earnings were $8.60 million, a decrease of -91.80%.

Analyst Forecast

According to 3 analysts, the average rating for NUS stock is "Hold." The 12-month stock price forecast is $20.83, which is an increase of 52.60% from the latest price.

Price Target

$20.83

(52.60% upside)

Analyst Consensus: Hold